RESULTS OF a MULTICENTRE UK‐WIDE STUDY EVALUATING THE EFFICACY OF BRENTUXIMAB VEDOTIN IN RELAPSED, REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN THE PRE‐TRANSPLANT NAÏVE SETTING. (June 2017)